Immunochemical studies on the role of reduced nicotinamide adenine dinucleotide phosphate-cytochrome c (P-450) reductase in drug oxidation.
D000632:Aminopyrine / Q000378:metabolism; D000814:Aniline Compounds / Q000378:metabolism; D000818:Animals; D001580:Benzopyrenes / Q000378:metabolism; D003580:Cytochromes; D003640:Dealkylation; D007106:Immune Sera / Q000494:pharmacology*; D005779:Immunodiffusion; D007136:Immunoglobulins; D008099:Liver / Q000201:enzymology; D008297:Male; D008748:Methylcholanthrene / Q000494:pharmacology; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology; D009249:NADP; D010084:Oxidation-Reduction; D010085:Oxidative Phosphorylation / Q000187:drug effects*; D010088:Oxidoreductases / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D010634:Phenobarbital / Q000494:pharmacology; D011817:Rabbits / Q000276:immunology; D051381:Rats
D000814:Aniline Compounds; D001580:Benzopyrenes; D003580:Cytochromes; D007106:Immune Sera; D007136:Immunoglobulins; D000632:Aminopyrine; D009249:NADP; D008748:Methylcholanthrene; D010088:Oxidoreductases; D010634:Phenobarbital